Related Experiment Video
Updated: Aug 13, 2026
04:37
Reproductive Techniques for Ovarian Monitoring and Control in Amphibians
Published on: May 12, 2019
Recombinant or urinary gonadotrophins - an Australian perspective
R J Norman1, S de Lacey, J X Wang
1Research Centre for Reproductive Health, Department of Obstetrics and Gynaecology, University of Adelaide, The Queen Elizabeth Hospital, Woodville, SA. Robert.Norman@adelaide.edu.au
Reproductive Biomedicine Online
|January 18, 2006
Summary
Australia
Area of Science:
- Reproductive endocrinology and assisted reproductive technologies.
Background:
- The transition to recombinant follicle-stimulating hormone (r-FSH) in gonadotrophin stimulation protocols.
- Analysis of national-level decision-making processes for adopting new reproductive technologies.
Discussion:
- Examining the factors influencing the sole adoption of recombinant FSH in a national context.
- Evaluating the Australian healthcare system's pathway to exclusively utilizing r-FSH for ovarian stimulation.
Key Insights:
- The Australian experience provides a model for other nations considering the exclusive use of recombinant FSH.
- Successful implementation involved a phased approach and consideration of clinical and economic factors.
Outlook:
- Potential for broader international adoption of similar strategies for gonadotrophin stimulation.
- Future research directions in optimizing national protocols for assisted reproduction.
